Highlights in Myelofibrosis Research at ASH 2024: Momelotinib in Anemic Patients

At the 66th American Society of Hematology Annual Meeting & Exposition there met a discussion panel of myelofibrosis experts moderated by Prithviraj Bose, MD, of MD Anderson Cancer Center. The panel included Francesca Palandri, MD, PhD, of Università di Bologna, Andrew Kuykendall, MD, of Moffitt Cancer Center, and Lucia Masarova, MD, of MD Anderson Cancer Center.

The topic for the concluding segment of the discussion was current clinical investigations into momelotinib for anemia in myelofibrosis. Dr. Masarova elaborated on a recent noteworthy study of the agent in patients refractory to ruxolitinib, and Dr. Bose spoke of upcoming research into combination of momelotinib with luspatercept.